LONDON--(BUSINESS WIRE)--Technavio’s latest market research report on the global triton X-100 market provides an analysis of the most important trends expected to impact the market outlook from ...
Strong demand and clinical progress against high-incidence diseases, calls for gene therapy manufacturers to scale up ...
Tegumental membranes of Schistosoma mansoni were disrupted by 0.2% Triton X-100 in Tris-maleate buffered/Kreb-Ringer's solution. Subsequent differential centrifugation of the disruption solution at ...
The banning of a chemical in the EU has worldwide implications for biopharmaceutical manufacturing, but, thankfully, the market already offers high-performing alternatives. That was the message of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback